tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
Alterity Therapeutics management to meet with Maxim
PremiumThe FlyAlterity Therapeutics management to meet with Maxim
3M ago
Alterity Therapeutics granted U.S. FDA Fast Track designation for ATH434
Premium
The Fly
Alterity Therapeutics granted U.S. FDA Fast Track designation for ATH434
3M ago
Alterity Therapeutics Reports Positive Phase 2 Trial Results for MSA Treatment
Premium
Company Announcements
Alterity Therapeutics Reports Positive Phase 2 Trial Results for MSA Treatment
3M ago
Alterity Therapeutics reports new data from ATH434 Phase 2 trial at AAN meeting
PremiumThe FlyAlterity Therapeutics reports new data from ATH434 Phase 2 trial at AAN meeting
3M ago
Alterity Therapeutics completes last patient visit in ATH434-202 Phase 2 trial
Premium
The Fly
Alterity Therapeutics completes last patient visit in ATH434-202 Phase 2 trial
4M ago
Alterity Therapeutics Completes Key Phase 2 Trial for MSA Treatment
Premium
Company Announcements
Alterity Therapeutics Completes Key Phase 2 Trial for MSA Treatment
4M ago
Alterity Therapeutics Issues Over 1 Billion New Shares
PremiumCompany AnnouncementsAlterity Therapeutics Issues Over 1 Billion New Shares
5M ago
Alterity Therapeutics raises A$40M in placement
Premium
The Fly
Alterity Therapeutics raises A$40M in placement
5M ago
Alterity Therapeutics Ltd (ADR) trading halted, news pending
Premium
The Fly
Alterity Therapeutics Ltd (ADR) trading halted, news pending
6M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100